This review highlights some important advances that have taken place in cannabinoid
research over the last four years. It focuses on novel ligands that are of interest either as …

There are at least two types of cannabinoid receptors, CB1 and CB2, both coupled to G-
proteins. CB1 receptors are present in the central nervous system and CB1 and CB2 …

It is widely accepted that non-endogenous compounds that target CB1 and/or CB2 receptors
possess therapeutic potential for the clinical management of an ever growing number of …

Mammalian tissues contain at least two types of cannabinoid receptor, CB 1, found mainly
on neurones and CB 2, found mainly in immune cells. Endogenous ligands for these …

Mandarin translation of abstract Medicines that activate cannabinoid CB1 and CB2 receptor
are already in the clinic. These are Cesamet®(nabilone), Marinol®(dronabinol; Δ9 …

Background: Since the discovery of cannabinoid receptors and their endogenous ligands in
early 1990s, the endocannabinoid system has been shown to play a vital role in several …

Research into the pharmacology of individual cannabinoids that began in the 1940s, several
decades after the presence of a cannabinoid was first detected in cannabis, is concisely …

The endocannabinoid system is a complex neuronal system involved in a number of
biological functions, like attention, anxiety, mood, memory, appetite, reward, and immune …

In the last 25 years data has grown exponentially dealing with the discovery of the
endocannabinoid system consisting of specific cannabinoid receptors, their endogenous …

The cannabinoid receptors CB1 and CB2 are family A, G-protein Coupled Receptors that
mediate the effects of cannabinoids, a class of compounds that are so named because the …